Published On: Thu, Nov 19th, 2015

Pfizer’s talks to acquire Allergan in a $150 billion deal

Pfizer is negotiating a price of $370 to $380 for each share, a person familiar with the discussions said.

BILL ACKMAN screen shot

Pfizer’s talks to acquire Allergan in a $150 billion deal that would see the US drug giant redomicile in Ireland accelerated on Wednesday, as the US Treasury prepared to clamp down further on such tax inversions.

Pfizer is negotiating a price of $370 to $380 for each Allergan share, a person familiar with the discussions said, asking not to be identified because the talks are confidential. Allergan shares ended trading on Wednesday at $310.8 per share. While negotiations have made progress in recent days, an agreement is not imminent and its timing remains uncertain following the Treasury’s disclosure that it would seek to tighten the rules on inversions, the source added.

Read the full story at Money Control 

Read more about: , , ,

About the Author

Wordpress site Developed by Fixing WordPress Problems